WELL HEALTH TECHNOLOGIES CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.83 CAD | +3.23% |
|
+4.08% | -0.52% |
| Sales 2024 * | 970M 708M | Sales 2025 * | 1.06B 776M | Capitalization | 943M 688M |
|---|---|---|---|---|---|
| Net income 2024 * | 1M 730K | Net income 2025 * | 5M 3.65M | EV / Sales 2024 * | 1.26 x |
| Net Debt 2024 * | 279M 204M | Net Debt 2025 * | 264M 193M | EV / Sales 2025 * | 1.14 x |
| P/E ratio 2024 * |
1,925
x | P/E ratio 2025 * |
-205
x | Employees | 1,507 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.07% |
More Fundamentals
* Assessed data
More news
Latest transcript on WELL Health Technologies Corp.
More recommendations
More press releases
More news
| 1 day | +3.23% | ||
| 1 week | +4.08% | ||
| Current month | +2.13% | ||
| 1 month | +7.58% | ||
| 3 months | -5.20% | ||
| Current year | -0.52% |
1 week
3.64
3.84
1 month
3.574.06
Current year
3.414.31
1 year
3.415.55
3 years
2.568.86
5 years
0.849.84
10 years
0.119.84
| Managers | Title | Age | Since |
|---|---|---|---|
Hamed Shahbazi
CEO | Chief Executive Officer | 49 | 10-11-22 |
Eva Fong
DFI | Director of Finance/CFO | - | - |
Brian Levinkind
DFI | Director of Finance/CFO | 59 | 10-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thomas Liston
BRD | Director/Board Member | 50 | 18-04-29 |
Ken Cawkell
BRD | Director/Board Member | 73 | 16-03-23 |
Hamed Shahbazi
CEO | Chief Executive Officer | 49 | 10-11-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.08% | 1 M€ | -.--% | - | |
| 0.03% | 146 M€ | -1.03% | - | |
| 0.02% | 29 M€ | -1.54% | - | |
| 0.02% | 746 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-05 | 3.83 | +3.23% | 526,627 |
| 24-06-04 | 3.71 | 0.00% | 214,949 |
| 24-06-03 | 3.71 | -1.07% | 307,153 |
| 24-05-31 | 3.75 | +1.90% | 828,979 |
| 24-05-30 | 3.68 | 0.00% | 420,752 |
Delayed Quote Toronto S.E., June 05, 2024 at 04:00 pm EDT
More quotes
WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcareâs in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.
Calendar
2024-06-12
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
3.83
CAD
Average target price
7.45
CAD
Spread / Average Target
+94.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.52% | 688M | |
| +24.47% | 88.24B | |
| -23.13% | 76.2B | |
| +2.04% | 26.63B | |
| +8.55% | 18.14B | |
| -12.89% | 16.69B | |
| +3.49% | 15.85B | |
| +76.87% | 13.61B | |
| +79.38% | 13.24B | |
| +38.44% | 12.72B |
- Stock Market
- Equities
- WELL Stock
